Goldman Sachs is a multinational investment bank and financial services company. It always sustains the trend due to its investments, funding, and most importantly, its comments. Reportedly, Samvardhana Motherson’s around 65 shares were bought by Goldman Sachs, and Navina secures $55 million. All these dragged the Company into the trend once again. Let’s explore the details.
Table of Contents
Goldman Sachs Bought Samvardhana Motherson’s Massive Shares.
According to reports, Goldman Sachs, a multinational investment bank, acquired ₹87 crore worth of shares of auto component major Samvardhana Motherson through an open market transaction. As per the block deal data on BSE, New York-based multinational Sachs purchased 65.48 lakh shares, through its arm Goldman Sachs (Singapore)Pte.
Picking the average share value at a price of ₹132.7 apiece led the transactional value to calculate around ₹86.90 crore. On the same day of purchase, the company’s shares fell by 2.3%, closing at ₹131.15 apiece on BSC. In its third quarter, October to December, Samvardhana Motherson reported a strong profit of ₹543 crore.
As of reports, at the time of this deal, Hong Kong-based asset management firm Kedensa Capital, through its arm Kadensa master fund, sold the same number of shares at the same price.
Goldman Sachs Invests $55 Million in Navina, AI-Powered Healthcare.
AI-powered clinical intelligence, Navina, secures big funding from Goldman Sachs. As of reports, Navina raised $55 million in a Series C funding round, bringing its total funding to $100 million. This investment marks an important step in the company’s expansion across the US healthcare market.
This investment was led by Groth Equity at Company Alternatives, with participation from existing investors Vertex Ventures Israel, Grove Venture, and Alive. Irit Kahan, managing director in growth equity at Sachs Alternatives, said that Navina stands at the forefront in this AI-driven healthcare industry modernization.
“AI is rapidly transforming modern healthcare, and Navina stands at the forefront of that transformation—delivering real, measurable value to thousands of clinicians, “Irit Kahan said. “Their deep integration into clinical workflows, unparalleled provider trust, and demonstrated ROI make them uniquely positioned to drive meaningful impact across the healthcare ecosystem, “further added.
“This investment is a powerful validation of Navina’s vision to improve patient outcomes and healthcare economics by breaking down data barriers with AI, ” said Ronen Lavi, Navina’s co-founder and CEO. He even showed his excitement, saying, “We’re thrilled to partner with a firm like Goldman Sachs as we enter this pivotal growth phase and expand our market reach.
Read This Also: iPhone 17 Pro Leaks: Massive Upgrades Expected, Here Are Anticipated Features Including Design, Specs, Camera, Price, And Date.
FAQs
What exactly does Goldman Sachs do?
It is a New York-headquartered international investment bank and financial services company. It provides several services, such as funding companies, acquiring shares, investment management, consumer and services management, securities, and more.
What is Goldman Sachs famous for?
It is famous for its incredible funding and acquiring companies’ shares to a vast level. Sometimes its statements leave it on trend.
Who is the CEO of Goldman Sachs?
America-based international Goldman Sachs currently holds David M. Solomon as its Chairman and Chief Executive Officer (CEO).
Who owns Goldman Sachs?
Sachs is a public company that is listed on the New York Stock Exchange (NYSE). Shareholders hold this company, which includes both institutional investors and individual investors.
Is Goldman Sachs a Bank?
It is an international investment bank and financial services company that was launched in 1869. Goldman Sachs was launched to make it easy for small businesses to access loans, as at that time, bank loans were scarce and expensive.
